Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a VR headset calm nerves before a scope?

NCT ID NCT07745959

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This trial tests whether using virtual reality (VR) before an upper gastrointestinal endoscopy can reduce patient anxiety, improve psychological readiness, and boost satisfaction after the procedure. About 52 adults scheduled for the procedure will be randomly assigned to either a VR experience or standard care. Anxiety and readiness are measured before the procedure, and satisfaction is assessed right after. The goal is to see if a simple, non-drug distraction can make the experience less stressful.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Virtual reality (VR) headset experience before the procedure
What this could lead to
If effective, VR could become a simple, drug-free way to help patients feel calmer and more prepared before endoscopic procedures.
What could go wrong
The trial is small (about 52 participants) and early, so results may not apply broadly. VR may cause discomfort in some people, and the effect on anxiety could be minimal.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 52 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 18 years or older * Scheduled to undergo upper gastrointestinal endoscopy * Able to understand and communicate in Turkish * Willing to participate in the study * Providing written informed consent Exclusion Criteria: * Presence of a diagnosed psychiatric or neurological disorder that may interfere with participation * Presence of a visual, hearing, head, face, or eye condition that prevents the use of a virtual reality headset * History of severe vertigo, motion sickness, or balance disorder * Development of severe dizziness, nausea, eye strain, or discomfort during the virtual reality intervention * Refusal to participate or withdrawal from the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Upper gastrointestinal disorders are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Atatürk University Research Hospital

    Erzurum, 25400, Turkey (Türkiye)